Identify and categorize drug-related problems in hospitalized surgical patients in China.
China
Drug-related problems
NCC-MERP classification
PCNE classification
Pharmacist
Pharmacy service
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
29
09
2018
accepted:
19
12
2018
pubmed:
6
1
2019
medline:
4
6
2019
entrez:
6
1
2019
Statut:
ppublish
Résumé
Background Data is lacking on types and severities of drug-related problems (DRPs) in hospitalized surgical patients in China. Objective To identify and categorize types and causes of DRPs, and to assess severities of these DRPs. Setting An academic teaching hospital in Chongqing, China. Method We retrospectively reviewed all medication orders for patients in six surgical departments during a six-month period. DRPs were classified using the Pharmaceutical Care Network Europe (PCNE) classification, and the severity ratings of these DRPs were based on the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) classification. Main outcome measure The number, types, causes and severities of the DRPs. Results A total of 291,944 medication orders in 10,643 patients were reviewed, and 3548 DRPs were identified. The average DRP number per patient was 0.3. The most common problem was treatment effectiveness (39.9%) and the major cause of the problems was dose selection (47.0%). Total 80.1% of the DRPs were rated at severity categories B to D (causing no or potential harm), whereas 19.9% were rated as categories E to H (causing actual harm). Conclusion DRPs are common in surgical patients, and prospective pharmacist medication order review services are needed to improve patients' pharmaceutical care.
Identifiants
pubmed: 30610549
doi: 10.1007/s11096-018-0777-7
pii: 10.1007/s11096-018-0777-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-17Subventions
Organisme : Chongqing Health and Family Planning Commission Scientific Research Projects
ID : 2018ZDXM014
Références
Pharm World Sci. 2008 Dec;30(6):768-76
pubmed: 18357512
J Clin Pharm Ther. 2012 Jun;37(3):276-81
pubmed: 21790687
Cardiology. 2012;123(4):219-22
pubmed: 23208189
Eur J Clin Pharmacol. 2014 Jul;70(7):799-815
pubmed: 24789053
Pharmazie. 2014 Apr;69(4):316-20
pubmed: 24791599
Br J Clin Pharmacol. 2014 May;77(5):873-9
pubmed: 24868576
PLoS One. 2015 Mar 20;10(3):e0117710
pubmed: 25793497